When Will Children Be Able To Get The Covid
In May 2021, the FDA expanded its emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine to include adolescents 12 to 15 years old. Previously, the Pfizer vaccine was authorized for use in children 16 years and older, while the Moderna and Johnson & Johnson vaccines are authorized for people 18 years and older. Moderna is also conducting age de-escalation studies, in which the vaccines are tested in groups of children of descending age. Johnson & Johnson plans to do the same.
The EUAs extended authorization was based on results from a Phase 3 trial testing its vaccine in children ages 12 to 15. The trial enrolled 2,260 adolescents half received the Pfizer mRNA vaccine, the other received a saltwater placebo. The immune response in the vaccinated adolescent group was even stronger than that in vaccinated 16- to 25-year-olds enrolled in an earlier study. In addition, a total of 16 symptomatic cases of COVID-19 were reported during the trial, all in the placebo group. Vaccine-related side effects were mild and included pain at the injection site, tiredness, headache, chills, muscle pain, fever, and joint pain. Pfizer has also started testing the vaccine in children younger than 12 years.
The age de-escalation studies are done to confirm that the vaccines are safe and effective for each age group. They also identify the optimal dose, which must be effective, but with tolerable side effects.
Daily Reported Doses Given By Manufacturer
Each line shows the seven-day average.
In December, federal regulators gave emergency use authorization to two-dose vaccines developed by Pfizer-BioNTech and Moderna. Regulators authorized Johnson & Johnsons one-dose vaccine in February, but recommended a pause in its use on April 13 because of reports of blood clots in a small number of patients. All 50 states paused or recommended that providers pause those vaccinations. The government ended the Johnson & Johnson pause on April 23, clearing the way for states to resume vaccinations.
Johnson & Johnson doses that were already administered or distributed continued to appear in the federal vaccination data during the halt in use.
On Aug. 12, regulators gave emergency use authorization for people with weakened immune systems to get a third dose of the Pfizer and Moderna vaccines. On Aug. 23, the federal government approved the Pfizer-BioNTech vaccine for those 16 and older, the first full approval of a Covid-19 vaccine in the country. Emergency use authorization of the vaccine continues for those ages 12 to 15 and third doses for those with weakened immune systems.
Where And How Does Armenia Procure Covid Vaccines
In September, 2020, the Ministry of Health joined the COVAX FACILITY initiative, with the purpose of securing the procurement of vaccines against COVID-19. The Ministry of Health is engaged in negotiations with all possible vaccine producers and international partners, with a view to procure vaccines against the coronavirus disease . At the same time negotiations are also underway to acquire the Sputnik-V vaccine.
Read Also: How Long For Covid Results Cvs
The Current Pace Of Vaccination Has Slowed Significantly Since This Spring No Vaccine Has Been Authorized For Children Under 12
Based on the seven-day average of people receiving a first or single dose each day.
But the pace of vaccinations varies across the country. Many states in the South and West, for example, have vaccinated a smaller share of their population with a first or single dose than in other regions.
How Much Do Vaccines Cost Per Dose
Most of the vaccines currently in use require two doses for a full vaccination.
The AstraZeneca-Oxford vaccine is the cheapest at only $4 per dose. The company has committed not to profit from the vaccine while the pandemic lasts. The vaccine also can be stored in normal refrigerators for up to six months, which makes it easier to transport and distribute in developing countries.
On the other hand, the mRNA vaccines from Pfizer-BioNTech and Moderna require a complicated cold chain to safely distribute them. These are also the most expensive vaccines. So far, the companies have been selling the majority of their doses to high-income countries, including the U.S., Canada and the European Union.
Because trials were conducted differently at different times, effectiveness figures cannot be directly compared.
Vaccines produced by Moderna and the Pfizer-BioNTech partnership appear to be 90% effective in preventing COVID-19 in a real-world setting.
AstraZeneca-Oxford vaccine was 76% effective at preventing symptomatic COVID-19 two weeks after the second dose and was 100% effective in stopping severe disease and hospitalization in a U.S.-based clinical trial, according to the company.
The J& J vaccine was shown to be 72% effective in moderate to severe disease and 85% effective in preventing the most severe disease.
Read Also: Does Cvs Do Pcr Test
Have The Covid Vaccines Effectively Protected Older Adults In The Real World
A small study conducted by the CDC and published in MMWR reports that the two mRNA vaccines have been as effective in older adults in the real world as they were in the clinical trials that led to authorization of their use.
The MMWR study was based on 417 patients, ages 65 years and older, who were admitted to a hospital for COVID-like symptoms between early January and late March 2021. All study participants were tested for COVID-19 and asked about their COVID vaccination history.
Researchers compared those who tested positive for COVID-19 and those who had another illness, and also looked at each of the participants COVID vaccination history. Based on their comparisons and calculations, the researchers found that fully vaccinated people reduce their risk of COVID-related hospitalization by 94%. In clinical trials, the vaccines were 95% and 94.1% effective. Effectiveness dropped to 64% in those who were partially vaccinated
Importantly, the vaccines did not protect against COVID-related hospitalization during the first two weeks after the first vaccine dose.
How Is Each State Doing
Some jurisdictions have been more efficient than others at administering their doses from the federal government.
*Includes doses provided to Palau, Micronesia and the Marshall Islands.
There are many reasons for variation among the states and territories, including demand for the vaccine, lags in data reporting and other logistical challenges. State progress varies by age group as well.
You May Like: Can You Take Advil After The Covid Vaccine
Is There Enough Vaccine
The UK had ordered more than 540 million doses of seven of the most promising vaccines, including the four so far approved for use. But the French vaccine maker Valneva says the UK government has scrapped a deal for 100m doses of its vaccine, which is yet to be approved.
An extra 35 million doses of the Pfizer-BioNTech vaccine were ordered in August, on top of another 60 million ordered earlier in the year, as part of the government’s plans for a vaccination booster programme.
But it has amended its original order of the Janssen single-dose vaccine from 30 million to 20 million doses, given the “unprecedented scale and pace” of the vaccination programme.
Ministers have also announced an eighth deal with biopharmaceutical company CureVac to develop vaccines against future variants.
It has placed an initial order for 50 million doses to be delivered later this year – if they are required.
As Breakthrough Cases Increase Is A Booster Shot Needed
In Virginia, total breakthrough cases resulting in death from Covid-19 went from 17 in mid-July to 42 on Friday.
In Oklahoma, where cases are up by 67 percent, state officials broke down the data to show that for residents who got Johnson & Johnson vaccine the incidents of breakthrough were greater at 160 per 100,000 people compared to 93 per 100,000 for Moderna.
Also Check: How Long Does It Take For Cvs Covid Test Results
Book Your Free Shot It’s Safe And Easy
COVID-19 vaccines help prevent you from getting infected and protect you from getting severely sick if you do get it. All vaccines are safe, effective and save lives.
Everyone born in 2009 or before can get their first and second doses now. Third doses are available to some people most at risk of severe illness.
NEW: AHS clinics and pharmacies now use the same centralized online booking system. You can also book your shot by calling 811, visiting a walk-in clinic, or contacting a doctor’s office.
- 78.8% of Albertans 12+ with at least 1 dose
- 70.8% of Albertans 12+ fully vaccinated
- $100 Debit Card
Get vaccinated to get a $100 debit card!
- Who’s eligible: Albertans 18 or older who got their first or second dose of an approved COVID-19 vaccine between September 3 and October 14, 2021.
- How to register: After vaccination, register online or by phone, starting on September 13. Detailed instructions will be posted at that time.
- How to claim: $100 debit cards will be delivered to you. Everyone who is registered and has a valid vaccination will receive a debit card.
Get vaccinated for your shot to win $1 million!
Which Vaccines Has The Fda Approved And Authorized For Covid
In August 2021, the FDA granted full approval to the mRNA COVID-19 vaccine developed by Pfizer and BioNTech. This vaccine had received emergency use authorization in December 2020. The mRNA COVID-19 vaccine developed by Moderna also received EUA in December 2020. The Johnson & Johnson adenovirus vaccine was granted EUA by the FDA in late February 2021. Use of the Johnson & Johnson vaccine resumed on April 23, 2021, after a temporary pause.
Don’t Miss: Did Hank Aaron Get Covid Vaccine
What Do We Know About The Moderna Covid
On December 18, 2020, the FDA granted emergency use authorization to an mRNA COVID-19 vaccine developed by Moderna in collaboration with scientists from the NIH. The vaccine is approved for use in people 18 years and older. This is the second COVID-19 vaccine authorized for use in the US.
The FDA granted EUA based on their own analysis of efficacy and safety data, as well as on the recommendation made by the Vaccines and Related Biological Products Advisory Committee . VRBPAC is a group of outside experts in infectious disease, vaccinology, microbiology, immunology, and other related fields.
In briefing documents submitted to the FDA, the Moderna vaccine showed an overall efficacy of 94.1% in preventing COVID-19. This study enrolled 30,400 adults half received the vaccine, half received a saltwater placebo shot. There were 196 infections among the study participants. Of these, 185 were in the placebo group and 11 were in the vaccine group. All 30 cases of severe COVID occurred in the placebo group, strongly suggesting indicating that the vaccine reduces risk of severe illness.
The vaccine was similarly effective in people older and younger than 65, in men and women, in people with and without medical conditions that put them at high risk for severe illness, and in different racial and ethnic groups.
The most common vaccine side effects were pain at the injection site, fatigue, headache, muscle pain, joint pain, and chills.
What Are The Promising Vaccines For Covid
Around the world, there are currently nearly 150 different COVID-19 vaccines in various stages of testing and development: phase 1 , phase 2 , and phase 3 trials in humans.
In the US, the FDA has granted full approval to the Pfizer/BioNTech mRNA COVID-19 vaccine, and emergency use authorization to the Moderna mRNA vaccine and the Johnson & Johnson adenovirus vaccine.
Two other vaccine approaches are also showing promise.
A central question for COVID-19 vaccines will be how long protection might last.
Don’t Miss: Breastfeeding Instead Of Vaccination
Map: How Many People Have Been Vaccinated In Each State
States prioritized at-risk populations to be vaccinated first, including medical staff, people in nursing homes or other long-term care facilities, essential workers, the elderly and people with medical conditions that put them at greater risk of becoming seriously ill with COVID-19.
Any person age 12 and older in the U.S. is now eligible to receive a COVID-19 vaccine.
Which Vaccines Have Been Approved So Far
On Feb. 26, 2021, Health Canada approved the AstraZeneca-Oxford COVID-19 vaccine.
On March 5, 2021, Johnson & Johnson’s COVID-19 vaccine became the first single-dose vaccine approved for use in Canada.
Health Canada on May 5, 2021.
May 20: The Canada map was updated to show first and second dose numbers for the provinces and territories. Quebec’s second dose vaccine numbers were added. The chart on vaccine doses distributed now also includes the percentage of doses used and the story text was updated to include additional information on Canada’s vaccine rollout.
Don’t Miss: Did Hank Aaron Get Covid Vaccine
What Is The Connection Between The Johnson & Johnson Covid
In July 2021, the FDA warned that the Johnson & Johnson COVID-19 vaccine may lead to a small but increased risk of Guillain-Barré syndrome . GBS is a disorder in which the body destroys its own nerve cells. It can lead to muscle weakness and sometimes paralysis, trouble breathing, or, rarely, death. The risk of developing GBS after receiving the J& J vaccine is very low, and benefits of vaccination still far outweigh the risks.
The FDAs warning was based on preliminary reports of about 100 cases of GBS that occurred in people who had received the J& J vaccine. To date, about 12.8 million people in the US have gotten the J& J vaccine. Most of the reported cases occurred in men ages 50 years and older, about two weeks after vaccination.
Almost all required hospitalization because GBS can affect the nerves to chest muscles and the diaphragm, making it difficult to breathe. Most people recover completely from GBS within a few months, but some never regain full strength.
Seek immediate medical attention if you experience any of the following symptoms after receiving the J& J COVID-19 vaccine:
- weakness or tingling sensations, especially in the legs or arms, thats worsening and spreading to other parts of the body
- difficulty walking
- difficulty with facial movement, including speaking, chewing, or swallowing
- double vision or inability to move eyes
- difficulty with bladder control or bowel function.
When Shouldnt You Get A Covid
If you have any questions about whether you should receive a COVID-19 vaccine, speak to your doctor. At present, people with the following health conditions should not receive a COVID-19 vaccine to avoid any possible adverse effects:
- If you have a history of severe allergic reactions to any ingredients of a COVID-19 vaccine.
- If you are currently sick or experiencing symptoms of COVID-19 .
Read Also: Can I Take Advil After Moderna Vaccine
Vaccine Breakthroughs And Variants
CDC continues to actively monitor vaccine safety and effectiveness against new and emerging variants for all FDA-authorized COVID-19 vaccines. Research shows that the FDA-authorized vaccines offer protection against severe disease, hospitalization, and death against currently circulating variants in the United States. However, some people who are fully vaccinated will get COVID-19.
The Delta variant is more contagious than previous variants of the virus that causes COVID-19. However, studies indicate that the vaccines used in the United States work well against the Delta variant, particularly in preventing severe disease and hospitalization. Overall, if there are more infections with SARS-CoV-2 there will be more vaccine breakthrough infections. However, the risk of infection, hospitalization, and death are all much lower in vaccinated compared to unvaccinated people. Therefore, everyone aged 12 years and older should get vaccinated to protect themselves from severe disease and death.
How Many Lives Have Coronavirus Vaccines Saved We Used State Data On Deaths And Vaccination Rates To Find Out
More than 200 million U.S. residents have gotten at least one shot of a COVID-19 vaccine with the expectation that the vaccines slow virus transmission and save lives.
For instance, some people in the U.S. have only been getting the first shot of a two-shot vaccine and are therefore less protected than a fully vaccinated person. Alternatively, vaccinated people are much less likely to transmit COVID-19 to others, including those who are not vaccinated. This could make vaccines more effective at a population level than in the clinical trials.
I am a health economist, and my team and I have been studying the effects of public policy interventions like vaccination have had on the pandemic. We wanted to know how many lives vaccines may have saved due to the states COVID-19 vaccination campaigns in the U.S.
Read Also: Why Does Everything Taste Bad To Me Suddenly
Where Are The Vaccines Coming From
The Pfizer-BioNTech jab – the first to be given the green light last December – is being imported from Puurs, Belgium.
A second vaccine, from Oxford University and AstraZeneca, is being made at a number of sites in Britain. Further doses are expected to come from the Serum Institute of India and the Halix plant in the Dutch city of Leiden.
The third, from Moderna, is coming from sites in Switzerland and Spain, via Belgium, while the Janssen vaccine, due to arrive later this year, is produced in the Netherlands by the Belgian firm, owned by Johnson & Johnson.
The UK is also lined up to receive another vaccine if approved for use.
The jab, manufactured by US firm Novavax, will be made in Stockton-on-Tees in north-east England.
When Shall Vaccination Against Covid Commence In Armenia
To this day 2,060 vaccine doses have been donated to Armenia by the Russian Direct Investment Fund. The current scope of vaccination includes health professionals involved in treating patiens with the coronavirus disease in institutions providing hospital care.
Negotiations with the purpose of procuring vaccines against COVID-19 continue.
You May Like: Cvs Covid Testing Results Time Frame